Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS)

European Journal of Dermatology

Volumn 17, Issue 5, 2007, Pages 397-404

  Furusyo, Norihiro ^a,b   Takeoka, Hiroaki ^b   Toyoda, Kazuhiro ^b   Murata, Masayuki ^a   Maeda, Shinji ^b   Ohnishi, Hachiro ^b   Fukiwake, Noriko ^a   Uchi, Hiroshi ^a   Furue, Masutaka ^a   Hayashi, Jun ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Epidemiology; Thymus and activation regulated chemokine

Indexed keywords

IMMUNOGLOBULIN E; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

AGE DISTRIBUTION; ARTICLE; ATOPIC DERMATITIS; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE ACTIVATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; REMISSION; UNIVERSITY HOSPITAL;

BIOLOGICAL MARKERS; CHEMOKINE CCL17; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; JAPAN; MALE; STATISTICS, NONPARAMETRIC;

EID: 34548719300     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0237     Document Type: Article

References (41)

1. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-55.
2. Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112: S128-S139.
3. Furue M, Terao H, Moroi Y, Koga T, Kubota Y, Nakayama J, et al. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J Dermatol 2004; 31: 277-83.
4. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994; 94: 870-6.
5. Pastore S, Mascia F, Girolomoni G. The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 2006; 16: 125-31.
6. Zlontik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000; 12: 121-7.
7. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
8. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271: 21514-21.
9. Zlotnik A, Yoshie O. The biology of chemokines and their receptors. Immunity 2000; 12: 121-7.
10. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535-41.
11. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110: 139-46.
12. George AO. Atopic dermatitis in Nigeria. Int J Dermatol 1989; 28: 237-9.
13. Williams H, Svensson A, Diepgen T, Naldi L, Coenraads PJ, Elsner P, et al., European Dermato-Epidemiology Network (EDEN). Epidemiology of skin diseases in Europe. Eur J Dermatol 2006; 16: 212-8.
14. Takeuchi M, Ueda H. Increase of atopic dermatitis (AD) in recent Japan. Envir Dermatol 2000; 7: 133-6.
15. Krause T, Koch A, Friborg J, Poulsen LK, Kristensen B, Melbye M. Frequency of atopy in the Arctic in 1987 and 1998. Lancet 2002; 360: 691-2.
16. Saeki H, Iizuka H, Mori Y, Akasaka T, Takagi H, Kitajima Y, et al. Prevalence of atopic dermatitis in Japanese elementary schoolchildren. Br J Dermatol 2005; 152: 110-4.
17. Hamada M, Furusyo N, Urabe K, Morita K, Nakahara T, Kinukawa N, et al. Prevalence of atopic dermatitis and serum IgE values in nursery school children in Ishigaki Island, Okinawa, Japan. J Dermatol 2005; 32: 248-55.
18. Fukiwake N, Furusyo N, Kubo N, Takeoka H, Toyoda K, Morita K, et al. Incidence of atopic dermatitis in nursery school children - a follow-up study from 2001 to 2004, Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Eur J Dermatol 2006; 16: 416-9.
19. Tagami H. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis. J Dermatol 1995; 22: 966-7.
20. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92: 44-7.
21. Morita A, Kikuoka S, Horikawa T, Bito T, Yamada H, Kanda M, et al. Evaluation of human thymus and activation-regulated chemokine concentrations in blood using a new sandwich ELISA based on monoclonal antibodies. Clin Chim Acta 2002; 322: 67-75.
22. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al., European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology / PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 152-69.
23. Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, et al. Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002; 57: 173-7.
24. Furukawa H, Nakamura K, Zheng X, Tojo M, Oyama N, Akiba H, et al. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004; 35: 35-42.
25. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60: 685-8.
26. Nomiyama H, Imai T, Kusuda J, Miura R, Callen DF, Yoshie O. Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet Cell Genet 1998; 81: 10-1.
27. Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001; 27: 372-3.
28. Tsunemi Y, Komine M, Sekiya T, Saeki H, Nakamura K, Hirai K, et al. The - 431C > T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients. Exp Dermatol 2004; 13: 715-9.
29. Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 1998; 102: 1933-41.
30. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001; 166: 2055-62.
31. Uchi H, Koga T, Urabe K, Moroi Y, Furue M. CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes. J Invest Dermatol 2003; 120: 983-9.
32. Moroi Y, Yu B, Urabe K, Koga T, Nakahara T, Dainichi T, et al. Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17). J Dermatol Sci 2004; 36: 186-8.
33. Furukawa H, Takahashi M, Nakamura K, Kaneko F. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004; 36: 165-72.
34. Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003; 14: 296-301.
35. Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children. Clin Exp Dermatol 2004; 29: 293-6.
36. Hon KL, Leung TF, Ma KC, Wong CK, Wan H, Lam CW. Serum concentration of IL-18 correlates with disease extent in young children with atopic dermatitis. Pediatr Dermatol 2004; 21: 619-22.
37. Consensus Conference Management of atopic dermatitis in children. Recommendations. Eur J Dermatol 2005; 15: 215-23 (short version).
38. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al., European Academy of Allergology. Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61: 969-87.
39. Hayashi T, Kawakami N, Kondo N, Agata H, Fukutomi O, Shimizu H, et al. Prevalence of and risk factors for allergic diseases: comparison of two cities in Japan. Ann Allergy Asthma Immunol 1995; 75: 525-9.
40. Agata H, Kawakami N, Kondo N, Hayashi T, Fukutomi O, Shimizu H, et al. Differences of genetic effects for the development of allergic diseases in two cities of Japan. Ann Allergy Asthma Immunol 1999; 82: 586-90.
41. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-38.